Key Transaction Details
- Transaction Type: Acquisition of manufacturing facility on slump sale basis
- Counterparty: Kaygee Laboratories Private Limited (KLPL), a related party
- Facility Location: Plot No. 6, New Industrial Area - II, Mandideep, Dist Raisen - 462046, Madhya Pradesh
- Assets Included: Leasehold land (22,304 sq mtr), industrial buildings (5,227 sq mtr), plant & machinery, licenses, permits, employees
- Consideration: ₹29.98 crores (Rupees Twenty-Nine Crores Ninety Eight Lakhs Only)
- Valuation Basis: Independent valuation report dated July 24, 2026 by S R Valuers (IBBI Registered Valuer: Regn No. IBBI/RV/04/2022/14808)
Voting Arrangements
- Cut-off Date: August 14, 2026
- Dispatch Date: August 18, 2026
- E-voting Period: August 20, 2026 (9:00 AM IST) to September 18, 2026 (5:00 PM IST)
- Service Provider: National Securities Depository Limited (NSDL)
- Scrutinizer: Mr. Alok Khairwar (FCS No. 10031, CP 12880) or alternatively Mr. Rajkumar Gupta (ACS No. 43015, CP 18582)
- Result Declaration: Within 2 working days from conclusion of e-voting
- Deemed Resolution Date: September 18, 2026 if approved
Financial Impact and Rationale
- Represents 33.22% of the company's annual turnover for FY 2025-26
- Funding: Partly from internal accruals and partly through borrowings
- Strategic Rationale: Achieve vertical integration in Pyridine, collidines and their derivatives; secure uninterrupted supply of chemical intermediates and APIs; enhance operational control and efficiency; eliminate outsourcing costs
- The facility was recently inspected and approved by WHO, Geneva
Historical Relationship with Related Party
- KLPL has been manufacturing chemical intermediates and APIs for Resonance under job work agreement
- Previous transactions with KLPL: ₹3.72 crores (April-June 2026) and ₹16.78 crores (April 2025-March 2026)
- KLPL Financials (FY 2024-25): Total Income ₹29.32 crores, PAT ₹9.21 crores, Net Worth ₹23.04 crores
Related Party Ownership Structure
- Mr. Prashant Godha: Non-Executive, Promoter Director of Resonance, Director of KLPL, holds 2.08% in Makers Laboratories Limited (which holds 45.48% in Resonance)
- Mr. Charchit Jain: Whole-time, Professional Director of Resonance, Director of KLPL
- KLPL Shareholding: Indirectly holds 14.35% of Makers Laboratories Limited
- Kaygee Investments Private Limited: Holds 8.77% of Resonance's equity share capital
Inspection Availability
Documents available for inspection from August 20, 2026 to September 19, 2026 via email request to investors@resonancesl.com